一种有效的的选择性的BBtk抑制剂,IC50:0.5nM。Ibrutinib is a potent and orally active BTK inhibitor. Ibrutinib binds to and inhibits BTK activity, preventing B-cell activation and B-cell-mediated signaling and inhibiting the growth of malignant B cells that overexpress BTK。